These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37875283)

  • 1. Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings.
    Senarathna SMDKG; Strunk T; Petrovski M; Woodland S; Martinez J; Chuang VTG; Batty KT
    Eur J Hosp Pharm; 2023 Oct; ():. PubMed ID: 37875283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
    Ross EL; Salinas A; Petty K; Her C; Carpenter JF
    Am J Health Syst Pharm; 2020 Nov; 77(23):1980-1985. PubMed ID: 32974650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
    De Silva DTN; Petrovski M; Strunk T; Mukadam N; Page-Sharp M; Moore BR; Batty KT
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1079-1087. PubMed ID: 38546840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
    Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
    World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical compatibility of pentoxifylline and intravenous medications.
    Senarathna SMDKG; Strunk T; Petrovski M; Batty KT
    Arch Dis Child; 2019 Mar; 104(3):292-295. PubMed ID: 30472662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three components.
    Nilsson N; Storesund I; Tho I; Nezvalova-Henriksen K
    Eur J Pediatr; 2022 Jul; 181(7):2685-2693. PubMed ID: 35422115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
    Thabit AK; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation.
    Bouchoud L; Fonzo-Christe C; Klingmüller M; Bonnabry P
    JPEN J Parenter Enteral Nutr; 2013; 37(3):416-24. PubMed ID: 23112277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical compatibility of MCT/LCT propofol emulsions with crystalloids during simulated Y-site administration.
    Szalai G; Katona G; Matuz M; Jójárt-Laczkovich O; Doró P
    Eur J Hosp Pharm; 2018 Oct; 25(e2):e139-e143. PubMed ID: 31157085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
    Wu G; Powers D; Yeung S; Chen F
    Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study.
    AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F
    Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.
    Riera P; Garrido-Alejos G; Cardenete J; Moliner E; Zapico-Muñiz E; Cardona D; Garin N
    Nutr Clin Pract; 2018 Oct; 33(5):694-700. PubMed ID: 29464781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.